# Livzon Mabpharm

Livzon Mabpharm is a Monoclonal Antibodies / Biologics based in Zhuhai, China.

## Overview

- **Organization type:** Monoclonal Antibodies / Biologics
- **Headquarters:** Zhuhai, China
- **Region:** Asia
- **Address:** Zhuhai, Guangdong, China
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** https://en.livzon.com.cn

## Regulatory record

- **Reports private funds:** No

## About

Livzon Mabpharm is a clinical-stage biotechnology company founded in 2010 in Zhuhai, China.

## Offices

- New York, United States

## Questions

### Who runs investment decisions at Livzon Mabpharm?

Livzon Mabpharm is a subsidiary of Livzon Pharmaceutical Group, a publicly traded company. Its strategic direction is set by the parent group's leadership, though specific executives for the Mabpharm unit are not consistently disclosed in public filings (per Livzon Group's annual reports).

### What investment stages does Livzon Mabpharm typically target?

Livzon Mabpharm does not function as an investment firm; it is a biotechnology company. Its activities are product-stage oriented, from preclinical discovery through clinical trials and regulatory approval, primarily in China (per the firm's pipeline disclosures).

### Which sectors does Livzon Mabpharm explicitly avoid?

Livzon Mabpharm focuses narrowly on monoclonal antibodies and biosimilars for oncology and autoimmune diseases, based on its publicly disclosed pipeline. No explicit avoidance policy is stated, but it has not publicly ventured into other therapeutic areas like vaccines or gene therapy (public record).

## Related profiles

- [Vice Media](https://altss.com/profile/vice-media-inc)
- [Kong Inc.](https://altss.com/profile/kong-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/livzon-mabpharm

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology